June 1, 2000
CampaMed Exec Receives Patent For C-Med-100
HILLSIDE, N.J.--Ronald Pero, chief scientific officer with CampaMed, has been issuedU.S. Patent #6,039,949 for C-MED-100 cat's claw. The ingredient is distributed exclusivelyby M.W. International Inc., a raw materials supplier based here. C-MED-100 is aproprietary extract of cat's claw (Uncaria tomentosa) with benefits to the immunesystem and DNA repair. For more information, see www.mwinternational.com.
You May Also Like
The rise of ashwagandha: A case study in a growing and evolving category – articleNov 28, 2023
Ashwagandha: Roots for wellness, leaves for soil – articleNov 28, 2023
Creatine, whey protein, beta-alanine among picks in NFL-style draft at SupplySide WestDec 01, 2023
Unleash the power of ‘combos’ supplements to meet consumer demand – infographicNov 22, 2023